Medical System and Liquid Circulation System for Brain Treatment
Summary
The USPTO has published a patent application (US20260083947A1) for a medical system and liquid circulation system designed for brain treatment. The system aims to efficiently deliver liquid to the brain while managing intracranial pressure fluctuations by controlling injection and discharge periods.
What changed
This document is a publication of a patent application by TERUMO KABUSHIKI KAISHA for a medical system and liquid circulation system for brain treatment. The application, filed on December 5, 2025, and published on March 26, 2026, describes a system that controls the injection and discharge of liquid into the body cavity to manage intracranial pressure. The core innovation lies in alternating periods of liquid injection without discharge and liquid discharge without injection, with the volumes being substantially equal.
While this is a patent application and not a regulatory rule, it signals potential future technological advancements in medical devices for neurological treatments. Companies involved in neurosurgery, medical device manufacturing, and pharmaceutical delivery systems should be aware of this patented technology. Compliance officers in these sectors may need to consider how such innovations could impact future product development, regulatory submissions, and market competition.
Archived snapshot
Mar 26, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
MEDICAL SYSTEM AND LIQUID CIRCULATION SYSTEM
Application US20260083947A1 Kind: A1 Mar 26, 2026
Assignee
TERUMO KABUSHIKI KAISHA
Inventors
Takashi KITAOKA
Abstract
A medical system and a liquid circulation system, which are capable of efficiently delivering the liquid to the treatment area of the brain while suppressing the fluctuations in the intracranial pressure. The medical system includes a control unit that executes control of setting a first period in which the liquid is injected into the body cavity and the liquid is not discharged from the body cavity and a second period in which the liquid is not injected into the body cavity and the liquid is discharged from the body cavity, and alternately repeating the first period and the second period to set an injection amount of the liquid in the first period to be substantially the same as a discharge amount of the liquid in the second period.
CPC Classifications
A61M 27/006 A61M 25/10184 A61M 2027/004 A61M 2202/0208 A61M 2202/0464
Filing Date
2025-12-05
Application No.
19409836
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Medical Devices (A61M)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Medical Devices (A61M) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.